Beauty Is Changing Its Game Plan for the Ozempic Era
From surgery to supplements, GLP-1 medications are radically evolving the beauty space. We unpack the latest innovations.
Opinion: Public health should embrace GLP-1 drugs without abandoning obesity prevention
Following the White House’s recent announcement of price reductions and expanded coverage for GLP-1 medications like Wegovy and Zepbound, many patients searching for obesity treatments are about to gain access to highly effective options. The implications for U.S. public health are vast. Read the rest…
Get the Government Out of the GLP-1 Market
Its involvement often leads to distortions and perverse incentives. Dr. Gilberto de Lima Lopes Jr. is right that the market for medications is imperfect, but it is often government that is the culprit (“ The Free Market Alone Won’t Cut GLP-1 Prices,” Letters, Nov. 21). Oncology, his speciality, is the …
Diagnostics, Vol. 15, Pages 3025: Beyond BMI: Rethinking Obesity Metrics and Cardiovascular Risk in the Era of Precision Medicine
Diagnostics, Vol. 15, Pages 3025: Beyond BMI: Rethinking Obesity Metrics and Cardiovascular Risk in the Era of Precision Medicine Diagnostics doi: 10.3390/diagnostics15233025 Authors: Maria-Daniela Tanasescu Andrei-Mihnea Rosu Alexandru Minca Andreea-Liana Rosu Maria-Mihaela Grigorie Delia Timofte Dorin Ionescu Obesity remains a dominant risk factor for cardiovascular disease, yet its classification continues to rely heavily on body […]
JCM, Vol. 14, Pages 8413: Epicardial Fat and Heart Failure in Type 2 Diabetes: Metabolism, Imaging and Novel Biomarkers—A Translational Perspective
JCM, Vol. 14, Pages 8413: Epicardial Fat and Heart Failure in Type 2 Diabetes: Metabolism, Imaging and Novel Biomarkers—A Translational Perspective Journal of Clinical Medicine doi: 10.3390/jcm14238413 Authors: Pedro Gil-Millan José Rives José Luis Sánchez-Quesada Antonio Pérez Heart failure (HF) is a major cardiovascular complication in people with type 2 diabetes (T2D), where heart failure […]
Thanksgiving foods to skip while taking ozempic or other weight-loss drugs, says dietitian
For individuals taking GLP‑1 medications such as Ozempic, Thanksgiving doesn’t have to be restrictive, but specific foods and beverages need caution. Dietitian Kylie Bensley recommends avoiding mac and cheese, candied yams, and heavy or cream-based alcoholic drinks because of their impact on blood sugar and digestion. Safer choices are protein packed foods, vegetables, light desserts […]
GLP-1 drugs may be associated with an increased risk of chronic cough, raising the need to study this mechanism and longitudinal cough dynamics objectively
submitted by /u/Cough_Geek [link] [comments]
Are Sexual Side Effects Emerging With GLP-1 Agonists?
GLP-1 receptor agonists affect sexual function differently across individuals and influencing libido and hormone levels in men and women during treatment. Medscape News Europe
Is Chronic Cough Another Side Effect of GLP-1 Drugs?
(MedPage Today) — GLP-1 receptor agonist use was associated with chronic cough regardless of a previous gastroesophageal reflux disease (GERD) diagnosis, a study of over 2 million people with type 2 diabetes suggested. Adults prescribed a GLP…
From blood sugar to brain relief: GLP-1 therapy slashes migraine frequency
Comments